EDGAR Filing Documents for 0001193125-16-612912

Form 8-K - Current report:

SEC Accession No. 0001193125-16-612912

Filing Date

2016-06-06

Accepted

2016-06-03 19:15:05

Documents

Period of Report

2016-06-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d202704d8k.htm	8-K	21146
2	EX-3.1	d202704dex31.htm	EX-3.1	75141
3	EX-10.1	d202704dex101.htm	EX-10.1	488294
4	EX-10.2	d202704dex102.htm	EX-10.2	74585
5	EX-10.3	d202704dex103.htm	EX-10.3	158711
6	EX-99.1	d202704dex991.htm	EX-99.1	9161
7	GRAPHIC	g202704g54z15.jpg	GRAPHIC	8029
	Complete submission text file	0001193125-16-612912.txt		839560

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109

Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998

PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)